Artesunate and Praziquantel for the Treatment of Schistosoma haematobium Infections: A Double‐Blind, Randomized, Placebo‐Controlled Study
The DOI matches its Crossref record.
Abstract
Recently, artemisinin derivatives have been shown to be efficacious in chemoprophylaxis of and chemotherapy for Schistosoma japonicum and S. mansoni infections. Therefore, a double-blind, randomized, placebo-controlled study was carried out to investigate the efficacy and tolerability of artesunate plus placebo and the combination of artesunate and praziquantel in the treatment of S. haematobium infections in Gabon. The 300 infected schoolchildren included in the study were randomized to receive artesunate plus placebo (n=90), praziquantel plus placebo (n=90), artesunate and praziquantel (n=90), or only placebo (n=30). End points were efficacy, assessed as cure on day 56, and tolerability. All treatment regimens were well tolerated. The praziquantel plus placebo-treated group attained a cure rate of 73%, artesunate plus placebo a rate of 27%, the combination of artesunate and praziquantel a rate of 81%, and placebo alone a rate of 20%. In summary, earlier findings of efficacy of artemisinin derivitives against S. mansoni and S. japonicum could not be confirmed in S. haematobium infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Artemisinins: Pharmacological actions beyond anti-malarial
Ho, W. E., Peh, H. Y., Chan, T. K., & Wong, W. S. F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.001 · Cited by 481
Conquering schistosomiasis in China: the long march
(2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.08.004 · Cited by 341
“haematobium (Borrmann et al., 2001; De Clercq et al., 2002; N’Goran et al., 2003; Inyang-Etoh et al., 2004).”
Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control
Utzinger, J., & Keiser, J. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.2.263 · Cited by 329
Chemotherapy of schistosomiasis: present and future
Caffrey, C. R. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.031 · Cited by 277
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Bergquist, R., Utzinger, J., & Keiser, J. (2017) · Infectious Diseases of Poverty · doi:10.1186/s40249-017-0286-2 · Cited by 195
“Subsequent clinical trials confirmed the protective efficacy for artemether [96, 97] and artesunate [98] and encouraged many articles discussing the advantage (and potential disadvantages) of including the artemisinins along with praziquantel in areas endemic for schistosomiasis and co-endemic for malaria [88, 90].”
BackgroundZwang, J., & Olliaro, P. L. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003286 · Cited by 185
Weathers, P. J., Elkholy, S., & Wobbe, K. K. (2006) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1079/ivp2006782 · Cited by 97
“, 2005), and parasites that cause schistosomiasis (Borrmann et al., 2001; Utzinger et al., 2001).”
BackgroundNafis, T., Akmal, M., Ram, M., Alam, P., Ahlawat, S., Mohd, A., & Abdin, M. Z. (2011) · Plant Biotechnology Reports · doi:10.1007/s11816-010-0156-x · Cited by 83
“It is also effective against other infectious diseases, such as schistosomiasis, human immunodeficiency virus (HIV), hepatitis B, and leishmaniasis (Jung and Schinazi 1994; Borrmann et al. 2001; Utzinger et al. 2001; Romero et al. 2005; Sen et al. 2007), and has recently been shown to be effective against a variety of…”
BackgroundDistribution of artemisinin and bioactive flavonoids from Artemisia annua L. during plant growth
Baraldi, R., Isacchi, B., Predieri, S., Marconi, G., Vincieri, F. F., & Bilia, A. R. (2008) · Biochemical Systematics and Ecology · doi:10.1016/j.bse.2007.11.002 · Cited by 77
HMG-CoA reductase limits artemisinin biosynthesis and accumulation in Artemisia annua L. plants
Ram, M., Khan, M. A., Jha, P., Khan, S., Kiran, U., Ahmad, M. M., Javed, S., & Abdin, M. Z. (2010) · Acta Physiologiae Plantarum · doi:10.1007/s11738-010-0470-5 · Cited by 59
“It has also been found effective against other infectious diseases such as schistosomiasis, HIV, hepatitis-B and leishmaniasis (Borrmann et al. 2001; Jung and Schinazi 1994; Utzinger et al. 2001; Romero et al. 2005; Sen et al. 2007).”
BackgroundArsenault, P. R., Vail, D. R., Wobbe, K. K., & Weathers, P. J. (2010) · Molecules · doi:10.3390/molecules15042302 · Cited by 54
“AN may also be an effective treatment for other health problems including those caused by cytomegalovirus, hepatitis B [3], schistosomiasis [4], and a variety of neoplasms [5].”
Khan, S., Ali, A., Ahmad, S., & Abdin, M. Z. (2015) · Biomedical Chromatography · doi:10.1002/bmc.3465 · Cited by 21
“It also possesses herbicidal activity and effectiveness against a variety of cancer cell lines (Borrmann et al., 2001; Chen and Zhang, 1987; Crespo-Ortiz and Wei, 2012; Duke et al., 1987; Efferth et al., 2001; Jung and Schinazi, 1994; Klayman, 1985; Romero et al., 2005; Sen et al., 2007; Singh and Lai, 2001).”
Background
Metadata
- Authors
- Borrmann, S., Szlezák, N., Faucher, J., Matsiegui, P., Neubauer, R., Binder, R. K., Lell, B., & Kremsner, P. G.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-11-15
- Volume
- 184
- Issue
- 10
- Pages
- 1363-1366
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2151867869
- Cited by
- 102
- References
- 0
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.